These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 6315843)
1. Decrease in the zinc turbidity test values in patients with liver cirrhosis: a possible indicator for impending hepatocellular carcinoma. Mishiro S; Hayashi S; Tanaka N; Sato Y; Yamada S; Ogata I; Takatsuki K; Ota Y; Fujiwara K; Oka H J Med; 1983; 14(3):185-92. PubMed ID: 6315843 [TBL] [Abstract][Full Text] [Related]
2. A contribution to early diagnosis of primary hepatic cell carcinoma occurring in patients with liver cirrhosis. Iwamura K Tokai J Exp Clin Med; 1982 May; 7(3):397-411. PubMed ID: 6181578 [TBL] [Abstract][Full Text] [Related]
3. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma. Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882 [TBL] [Abstract][Full Text] [Related]
4. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis. Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701 [TBL] [Abstract][Full Text] [Related]
5. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576 [TBL] [Abstract][Full Text] [Related]
6. Clinical and morphological study of hepatocellular carcinoma associated with liver cirrhosis. Antón MD; Serra MA; Del Olmo J; Rodrigo JM Rev Esp Enferm Dig; 1997 Aug; 89(8):599-610. PubMed ID: 9299919 [TBL] [Abstract][Full Text] [Related]
7. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis. Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943 [TBL] [Abstract][Full Text] [Related]
8. Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists. Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H Hepatogastroenterology; 2004; 51(56):564-9. PubMed ID: 15086203 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey. Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558 [TBL] [Abstract][Full Text] [Related]
12. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis]. Bolondi L; Gaiani S; Casali A; Serra C; Piscaglia F Radiol Med; 1997; 94(1-2):4-7. PubMed ID: 9424649 [TBL] [Abstract][Full Text] [Related]
13. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756 [TBL] [Abstract][Full Text] [Related]
14. Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma. Kogo M; Sato N; Yoneyama K; Imawari M; Kiuchi Y Hepatogastroenterology; 2007; 54(79):2049-54. PubMed ID: 18251158 [TBL] [Abstract][Full Text] [Related]
16. [Hepatic cirrhosis and hepatocarcinoma. Diagnostic value of echography]. Mauduit Astolfi I; Nogueira Soriano JM; Talegón Meléndez A Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):701-4. PubMed ID: 2830646 [No Abstract] [Full Text] [Related]
17. Undetected hepatocellular carcinoma in patients undergoing liver transplantation: is associated with favorable outcome. Urahashi T; Lynch SV; Kim YH; Balderson GA; Fawcett JW; Crawford DH; Strong RW Hepatogastroenterology; 2007 Jun; 54(76):1192-5. PubMed ID: 17629068 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and etiologic features of hepatocarcinoma in Sicily]. Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015 [TBL] [Abstract][Full Text] [Related]
19. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142 [TBL] [Abstract][Full Text] [Related]
20. Zinc metabolism after transcatheter arterial embolization for hepatocellular carcinoma. Ohmoto K; Yamamoto S Hepatogastroenterology; 1998; 45(22):1082-4. PubMed ID: 9756010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]